Table of Contents
What changed
Revenue rebounded 8.4% to NZ$2,552.1m and EBITDA rose 6.4% to NZ$340.9m, but the recovery did not reach the bottom line. PBT fell 7.8% to NZ$161.2m and NPAT fell 8.0% to NZ$114.6m, implying the cost lines below EBITDA (depreciation, amortisation and finance costs) absorbed more than the full operating gain. Operating cash flow edged up 2.7% to NZ$191.8m, but cash on hand fell NZ$86.6m to NZ$147.9m while gross borrowings rose to NZ$236.3m, flipping the group from a small net cash position to net debt of around NZ$88.4m. Trade debtors rose 16.4% to NZ$721.1m, outpacing revenue growth. The interim dividend was held flat at NZ$0.85 per share.
What matters
- Earnings drag is structural, not tax-driven. The effective tax rate was essentially unchanged at 28.9% versus 28.8%, so the PBT fall of 7.8% is the cleanest read on operating earnings quality. Revenue grew 8.4% and EBITDA grew 6.4%, yet PBT fell; the squeeze is occurring in depreciation, amortisation and/or finance costs, consistent with a heavy property and capex footprint now carrying higher financing cost.
- Balance-sheet direction has reversed. Cash down NZ$86.6m, borrowings up NZ$22.6m, and working capital tied up in receivables up NZ$101.4m together explain the move from net cash to net debt. Net-debt-to-EBITDA is still modest at roughly 0.3x, but the direction is unambiguously weaker.
- Dividend is not covered by free cash. Pre-lease FCF of NZ$68.1m represents a payout ratio of about 126% against the NZ$0.85 interim dividend, and 74.7% of NPAT. The current distribution therefore relies on cash buffers or debt capacity, not in-period cash generation.
Expectations
No quantified forward-work or earnings targets were disclosed in the extracted materials, so this release cannot be measured against management guidance. Against FY24 shape, annualised HY25 revenue of NZ$5.10b sits about 8.2% above FY24's NZ$4.72b, and FY24 was second-half weighted on EBITDA (H1 only 44.5% of full-year EBITDA) but first-half weighted on NPAT (H1 at 59.7%). If that seasonal pattern repeats, EBITDA momentum into the second half is supportable, but NPAT is likely to step down sequentially, and the full-year NPAT trajectory depends heavily on whether the sub-EBITDA cost creep persists.
Quality of result
The revenue and EBITDA recovery look genuine, but several features reduce the quality of the reported result. Cash conversion weakened, with OCF-to-EBITDA slipping to 56.3% from 58.3%, because EBITDA grew faster than operating cash flow. Receivable days stretched to 51.4 from 47.9, consuming NZ$101.4m of incremental working capital and accounting for much of the cash drawdown. Capex of NZ$123.7m remained heavy at 4.8% of revenue. The gap between headline EBITDA growth and PBT decline indicates that fixed-cost absorption below the EBITDA line, not one-off items, is doing the damage – no non-recurring items were flagged in the extracted disclosures.
Unresolved
- How much of the below-EBITDA cost increase is depreciation from recently opened facilities (transient) versus structurally higher finance costs (durable)?
- Why did trade debtors grow roughly twice as fast as revenue, and is this a customer-mix shift, a collection issue, or period-end timing?
- With the dividend uncovered by FCF and the balance sheet now in net debt, what is management's tolerance for further leverage given the ongoing capex programme?
- No segment-level disclosure, forward-work book, or customer concentration detail was extracted, so the geographic and divisional drivers of the margin squeeze remain opaque.
This briefing cannot assess segment performance, regional mix, or valuation, because segment data, guidance, and a market price were not supplied in the extracted materials.
Key metrics
| Metric | HY25 | HY24 | Change |
|---|---|---|---|
| Revenue | $2552.1m | $2355.0m | +8.4% ↑ |
| EBITDA | $340.9m | $320.3m | +6.4% ↑ |
| Net profit after tax | $114.6m | $124.5m | -8.0% ↓ |
| Net cash inflow from operating activities | $191.8m | $186.8m | +2.7% ↑ |
| Interim dividend per share | 85.0c | 85.0c | flat |
| Cash and cash equivalents | $147.9m | $234.5m | -36.9% ↓ |
| Total assets | $3959.8m | $3494.4m | +13.3% ↑ |
Reference: annolyse.ai/briefings/mft-hy25
Analytical metrics
| Metric | HY25 | HY24 | Context |
|---|---|---|---|
| PBT growth | -7.8% | — | — |
| Effective tax rate | 28.9% | 28.8% | — |
| OCF / EBITDA (cash conversion) | 56.3% | 58.3% | deteriorated |
| FCF pre-lease | $68.1m | $58.9m | +$9.1m |
| FCF post-lease | $68.1m | $58.9m | +$9.1m |
| FCF / NPAT | 59.4% | 47.3% | complementary conversion metric |
| Capex % revenue | 4.8% | 5.4% | — |
| Capex | −$123.7m | −$127.9m | +$4.1m |
| Debtor days | 51.4 | 47.9 | +3.5 days |
| Operating working capital | $721.1m | $619.7m | +$101.4m absorbed |
| Trade debtors | $721.1m | $619.7m | +$101.4m |
| Net debt | $88.4m | −$20.9m | +$109.2m |
| Net debt / EBITDA | 0.26x | -0.07x | Weakening |
| Gross borrowings | $236.3m | $213.7m | +$22.6m |
| Payout ratio vs NPAT | 74.7% | — | — |
| Payout ratio vs FCF pre-lease | 125.8% | — | not covered |
| ROE (annualised) | 6.1% | 7.0% | Weakening |
| HY24 share of FY24 revenue | 49.9% | — | Other half was 50.1% |
| HY24 share of FY24 EBITDA | 44.5% | — | Other half was 55.5% |
| HY24 share of FY24 NPAT | 59.7% | — | Other half was 40.3% |
| Profit from continuing operations | $114.6m | $124.5m | −$10.0m |
Reference: annolyse.ai/briefings/mft-hy25
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.